Barclays’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Barclays’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35,824	Closed	-$25	–	5492
2023 Q4	$25	Sell	35,824 -3,546,371	-99%	-$110K	﹤0.01%	5193
2023 Q3	$179K	Buy	3,582,195 +1,058,820	+42%	+$144K	﹤0.01%	3350
2023 Q2	$530K	Buy	2,523,375 +567,802	+29%	+$142K	﹤0.01%	2720
2023 Q1	$313K	Buy	1,955,573 +874,102	+81%	+$258K	﹤0.01%	3558
2022 Q4	$238K	Sell	1,081,471 -593,759	-35%	-$515K	﹤0.01%	3749
2022 Q3	$4.42M	Buy	1,675,230 +1,464,728	+696%	+$2.16M	﹤0.01%	1236
2022 Q2	$143K	Sell	210,502 -194,498	-48%	-$201K	﹤0.01%	3603
2022 Q1	$640K	Buy	+405,000	New	+$584K	﹤0.01%	2720

Barclays's CANO.WS Position: Q1 2024 in Review

Barclays sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q1 2024, closing a stake of 35,824 shares — an estimated $25 sold.

Barclays first reported a position in CANO.WS in Q1 2022 and held it in 8 quarters. The position peaked at $4.42M in Q3 2022. 0 funds tracked by Wall St. Rank hold CANO.WS as of Q1 2024.

Barclays reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q1 2024 after selling out during the quarter.
Barclays sold 35,824 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q1 2024, an estimated $25.
Barclays first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q1 2022 and held it in 8 quarters.
Barclays's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $4.42M in Q3 2022.
0 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.